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· A thin plate spline deformation, adapting the original fluence0 into 
fluenceX. In contrast to Ref.1 marker positions are used instead of 
organ contours. 
· An adapted leaf motion, calculated in Eclipse (Varian Medical 
Systems, Palo Alto, CA). 
For the dosimetric step ray tracing5 is used to calculate the 
radiological path length d, from the source to each marker. Next, the 
tissue to phantom ratio, TPR(0.5,d), is calculated using a fixed 0.5cm 
field size. The TPRplanX / TPRplan0-median over the different markers 
rescales the number of monitor units of each beam. 
For validation a 5 beam sliding window IMRT plan is optimized for the 
TG119 prostate structures2. The phantom is extended with 4 markers 
and bony anatomy. The initial plan0 delivers 77Gy(2.2Gy/Fr). 
Fractions are simulated by applying translations and isotropic scaling 
using literature values (Table 1). The isotropic expansion is derived 
from the shrinkage factor, and is used to evaluate the robustness of 
our approach. 
 
 Type Magnitude Structures 
T1 Rigid translation3 
(Lat, Vrt, Lng) [mm] 
( -0.4, 2.5, -2.6) All 
T2 ( -4.7, 8.2, -8.0) 
T3 (-9.0, 14.9, -13.4) 
S1 Isotropic shrinkage4 Expansion factor = 0.9 Target + Markers
E1 Isotropic expansion4 Expansion factor = 1.1 
Table 1: Overview of the applied deformations. The type and 
magnitude are listed in column 2 and 3. Column 4 indicates on which 
structures the deformations are applied. 
 
Results: Results are compared to plan0 and our clinical standard: 
shifting of the phantom according to the detected marker positions, 
see Figure 1. 
The combination of the geometric and dosimetric adaptation results in 
an identical target coverage as was intended (planX = plan0). The 
geometric adaptation alone reduces target coverage compared to 
plan0 (upper left), similar as our clinical practice (upper row, dashed 
line (left) vs. solid gray line (right)). All translations have similar 
results. 
  Figure 1. The DVH and conformity results. DVHs of a transformation 
(T2 upper row), and target shrinkage (S1,E1 lower row) are depicted. 
 
For S1 and E1 a strongly improved conformity is observed for the 
adaptation compared to the clinical practice (Figure1). The 
adaptation ensures a stable, better CI95 compared to our clinical 
practice for all applied deformations, this indicates better OAR 
protection. 
Conclusions: Target coverage, conformity, and as consequence OAR 
protection is improved by the presented non-MU preserving 
adaptation. 
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Purpose/Objective: To analyse the accuracy of image-guidance using 
the cone-beam CT technology of the VERO SBRT system in stereotactic 
radiotherapy of lung tumors.  
Materials and Methods: So far 22 consecutive patients have been 
treated with stereotactic treatment using the VERO system (BrainLAB 
AG, Mitsubishi Heavy Industries). A free breathing CT scan and a 10-
phase respiration correlated 4D-CT to allow patient-specific motion 
assessment were acquired with a slice thickness of 2.5 mm. The Real-
time Position Management respiratory gating system (RPM, Varian) 
was used to generate the external breathing signal and to 
retrospectively correlate cine CT images with the breathing phases. 
Patients, positioned supine with an arm holder (Posirest, Civco), were 
trained to achieve a regular breathing with the aid of a wearable 
display showing the breathing cycle. The internal target volume (ITV) 
was obtained contouring the tumor on the reconstructed maximum 
intensity projection and the mean intensity projection CT images. The 
PTV was generated with a safety margin of 5 mm to account for setup 
uncertainties. Treatment plans, consisting of 1-3 non coplanar 
conformal dynamic arcs or multiple IMRT fields, were generated for 
the VERO system. Doses between 25 and 54 Gy were delivered to the 
isocenter in 3 to 5 fractions. Patients were setup according to 
Exactrac and target localization was achieved with a kV-CBCT. Due to 
the limited field of view, in most of the cases the vertebral spine was 
not visible for evaluation of the patient set-up. The clipbox for 
automatic soft-tissue registration of the CBCT and the planning CT 
was confined around the lesion. The radiation oncologist then 
performed a manual registration to adjust the position of the ITV and 
PTV to the motion-blurred tumor in all three planes in the CBCT. 
Translational and rotational target localization errors were corrected 
with the 5 degree-of-freedom robotic couch and the ring rotation. A 
verification CBCT was acquired after correction to evaluate residual 
errors. If residual error was greater than 2 mm in any direction, a 
second correction was made and another CBCT acquired. 
Results: In the table are shown the group mean, the systematic (Σ) 
and random (σ) component of the tumor localization errors and 
residual errors after correction, in terms of translations and rotations. 
Data were obtained from the analysis of 168 CBCTs. The mean 3D 
vector at initial set-up was 5.7±1.4 mm, while was significantly 
reduced to 1.4±0.6 mm after 6D automatic correction.  
 
Translations (mm) Rotations (°) 
LR  SI  AP  3D vector roll  pitch yaw 
Tumor localization Group mean 0.5 1.7 -3.4 5.7 0.6 0.0 0.1 
error Σ 1.2 3.2 1.9 1.4 0.7 1.0 1.0 
σ 1.7 2.3 1.9 1.9 0.8 0.9 1.4 
Residual error Group mean -0.1 0.0 0.0 1.4 -0.1 0.0 0.0 
Σ 0.5 0.7 0.6 0.6 0.3 0.2 0.3 
σ 0.5 1.0 1.0 1.0 0.4 0.4 0.3 
 
Conclusions: On-line CBCT image guidance and automatic 6D 
correction available on the VERO system allowed a very accurate 
tumor localization in lung stereotactic treatments. A post-treatment 
CBCT will be acquired in the next group of patients to assess the 
safety margins required to compensate for residual positional 
uncertainties and intra-fraction tumor displacement. 
   
PO-0849   
Dose coverage of lymph nodes in treatments corrected for daily 
baseline shift of the primary tumour 
T.B. Nielsen1, C. Brink1 
1Laboratory of Radiation Physics, Odense University Hospital, DK-5000 
Odense, Denmark  
 
Purpose/Objective: Treatment planning and irradiation of lung cancer 
patients are often based on the mid-ventilation phase in order to 
minimize planning margins. The primary lung tumour and involved 
lymph node located in the mediastinum region can have different 
respiratory patterns. There can be a systematic baseline shift across 
the entire treatment course between the primary tumour and the 
lymph node as well as daily random baseline variations. It is desirable 
to correct for baseline shifts that occurs daily for the primary lung 
tumour but that might cause a discrepancy between the planned and 
delivered dose distribution to the lymph node. This study investigates 
the dose coverage of the lymph node when the entire dose 
distribution is shifted in accordance with baseline shift of the primary 
tumour. 
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Materials and Methods: Standard 3D IMRT treatment plans were 
created for 10 NSCLC patients with lymph node involvement based on 
the mid-ventilation phase with a prescribed dose of 66Gy/33F. A CTV 
margin of 1 cm was used around the lymph nodes and was adjusted in 
order to exclude bone tissue and larger blood vessels. Patient-specific 
PTV margins of 0.7-1.0 cm were calculated using a probabilistic 
margin formula and were applied to the CTV. Random day-to-day 
variations of the baseline shift between the primary tumour and the 
CTV-node were simulated by blurring the dose distribution in either 
the cranial-caudal (CC), left-right (LR) or anterior-posterior (AP) 
directions with a Gaussian error distribution. Furthermore, a 
systematic shift between the lymph node and the primary tumour was 
simulated by displacing the dose distribution relative to the 
delineated structures with both 0.25 cm and 0.50 cm. Sufficient dose 
coverage of the involved lymph node was defined as the minimum 
dose (D98%) of the CTV-node was larger than 95% of the prescribed 
dose for 90% of the patients. 
Results: The figure shows the minimum dose of the CTV-node for 90% 
of the patients as a function of the random peak-to-peak variation in 
the CC direction for the different types of simulations. Dose coverage 
was sufficient for all data points above 95% of the prescribed dose, 
which is indicated by the dashed line in the figure. Table 1 
summarises the acceptable random peak-to-peak variations in the CC, 





Conclusions: Dose coverage of the CTV-node can be achieved with 
large random peak-to-peak variations between the primary tumour 
and CTV-node in treatments corrected for daily baseline shift of the 
primary tumour. With the introduction of a systematic shift during the 
treatment course the random peak-to-peak variation was only slightly 
reduced. However, large systematic shifts are undesirable and should 
justify a re-planning of the treatment. 
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Purpose/Objective: 3D position verification in breast radiotherapy 
with kV-CBCT is very accurate but time-consuming, especially in gated 
breast radiotherapy. Due to the need for uniform position verification 
in non-gated and gated conformal breast radiotherapy, the accuracy 
of the patient position adjustment based on the online matching of 
two orthogonal kV fields was investigated. 
Materials and Methods: Twenty breast cancer patients and 20 
patients treated for breast cancer in combination with internal 
mammary-medial supraclavicular (IMMS) lymph node irradiation, i.e. 
locoregional breast treatment, were included in the study. Each 
treatment was performed on a Varian Clinac 2100C/D linear 
accelerator equipped with an amorphous-silicon EPID and an OBI 
system (Varian Medical Systems, Inc.). The patient positioning and 
isocenter shift were checked with online paired kV-kV matching using 
the ribs close to the isocenter. One of the orthogonal kV fields was 
parallel to one of the tangential field directions (see figure). Only 
translations were adjusted. The new patient position was verified 
during 5 fractions by MV imaging of both tangential breast fields and 
kV imaging of the MS-field. All images were matched in Offline Review 
(Varian Medical Systems, Inc.) using bony anatomy. The differences 
for each tangential field were reported as ΔCLD (Central-Lung-
Distance, i.e. the distance between the deep field edge and the 
interior chest wall at field central axis), and ΔC(ranio)C(audal). The 
differences for the MS-field were reported as ΔVrt, i.e. ΔVertical, ΔCC 
and ΔLat(eral). The range of the patient mean errors, the percentage 
of the patient population with an absolute value of the mean error 
larger than 2mm, the population mean, population systematic error 
and population random error were reported. 
Results: For breast cancer treatment with and without IMMS 
irradiation, a mean CLD error ranging from -1mm to 2mm and from -
1mm to 3mm, respectively, was found. Only 5% of the breast cancer 
patients had a mean ΔCLD > 2mm. The patient mean ΔCC ranged from 
-3mm to 3mm and from 0mm to 3mm for the breast treatments and 
the locoregional breast treatments, respectively. For 10% of the 
patients, the mean ΔCC was larger than 2mm, irrespective of the 
treatment. None of the population systematic errors were larger than 
1mm and none of the population random errors were larger than 
2mm, irrespective of the patient group (see table). The population 
systematic and random errors measured in the MS-field were smaller 
than 1mm for all three directions (see table). 
 
 
Conclusions: The new position verification protocol is appropriate for 
accurate, uniform and quick 3D position verification in non-gated 
(locoregional) breast radiotherapy and easily extendible to gated 
breast radiotherapy. An important property of the protocol is the low 
imaging dose to both the target volume and the healthy tissue thanks 
to the combination of the kV imaging and the field orientation. 
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Purpose/Objective: Uncertainties in patient positioning are a crucial 
issue to be considered when treating patients with particles. In this 
study we aim to quantify the effect of small patient misalignment for 
different proton dose delivery techniques.  
Materials and Methods: We have investigatedthree different delivery 
techniques: 3D spot-scanning (3DSS), distal edge tracking(DET) and 
